Life Science Investing Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
Life Science Investing Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3
Life Science Investing Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025
LaFleur Minerals Closes $1.66 Million Flow-Through Offering to Advance Drilling and PEA-Related Work at its Swanson Gold Deposit
